ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
23 announcements with these filters
KMC Speciality Hospitals has intimated a board meeting on 13 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The filing is a prior intimation, with agenda items only proposed.
The filing reports the quarterly shareholding pattern for KMC Speciality Hospitals (India) Ltd as of September 30, 2026. It includes disclosures regarding indirect promoter encumbrances.
KMC Speciality Hospitals (India) Ltd submitted a revised disclosure under SEBI (SAST) Regulations regarding the encumbrance of shares by its promoter group to the BSE.
KMC Speciality Hospitals (India) Limited held its 43rd Annual General Meeting on September 28, 2026. The meeting transacted ordinary and special business as per the notice.
Promoter Sri Kauvery Medical Care (India) Ltd has created an encumbrance on 27,41,435 equity shares of KMC Speciality Hospitals (India) Ltd.
KMC Speciality Hospitals (India) Limited has filed its Annual Report and notice for the 43rd Annual General Meeting scheduled for September 28, 2026.
KMC Speciality Hospitals (India) Ltd has scheduled its 43rd Annual General Meeting for September 28, 2026, via video conferencing to transact special business.
KMC Speciality Hospitals (India) Ltd reported robust Q1 FY27 results with a 39% increase in Total Income and a 120% surge in PAT.
KMC Speciality Hospitals appointed M/s. G Sugumar & Co as Cost Auditors for a 12-month term. This routine appointment follows the company's board meeting outcome.
KMC Speciality Hospitals (India) Ltd approved a Rs. 519 Crore capacity expansion. The project adds 591 beds across Trichy and Bengaluru campuses by FY30.
KMC Speciality Hospitals (India) Ltd reported revenue from operations of ₹91.8 Cr (+37.8% YoY) and net profit of ₹16.6 Cr (+121.3% YoY) for Q1 FY27.
Catalyst Trusteeship Ltd disclosed the creation of pledges and non-disposal undertakings over shares of SKMCIL. This indirectly impacts KMC Speciality Hospitals, where SKMCIL holds 75% stake.
KMC Speciality Hospitals (India) Limited scheduled a board meeting on August 14, 2026, to approve unaudited financial results for the quarter ended June 30, 2026.
Sri Kauvery Medical Care (India) Limited, the promoter of KMC Speciality Hospitals, reported the creation of indirect encumbrances. This involves pledges over shares of the holding company.
KMC Speciality Hospitals delivered robust Q4 FY26 performance with total income growing 36% YoY to ₹84.2 Cr and PAT surging 225% to ₹14.6 Cr, driven by new facility scaling.
KMC Speciality Hospitals (India) Limited submitted its Annual Secretarial Compliance Report for FY2026. The report confirms compliance with SEBI listing regulations and governance standards.
KMC Speciality Hospitals approved a ₹62.50 Crore land purchase in Tiruchirapalli for expansion. The acquisition facilitates adding approximately 300 beds to its existing infrastructure.
KMC Speciality Hospitals (India) Ltd appointed Grant Thornton Bharat LLP as Internal Auditors for FY 2026-27. This brings global professional expertise to the company's internal controls.
KMC Speciality Hospitals (India) Ltd reported revenue from operations of ₹82.3 Cr (+35.1% YoY) and net profit of ₹14.6 Cr (+224.4% YoY) for Q4 FY26.
KMC Speciality Hospitals reported audited standalone financial results for the year ended March 31, 2026. The filing includes an unmodified auditor's report from Deloitte Haskins & Sells.
KMC Speciality Hospitals (India) scheduled a board meeting for May 29, 2026. Directors will consider audited financial results for the quarter and year ended March 2026.
KMC Speciality Hospitals (India) Ltd submitted its initial disclosure under the SEBI Large Corporate framework. The company reported outstanding borrowings of ₹71.35 Crore as of March 31, 2026, and maintains an AA- credit rating from India Ratings and Research. It confirmed it does not meet the 'Large Corporate' criteria for the 2026 financial year.
KMC Speciality Hospitals (India) Ltd submitted a confirmation certificate from its RTA, Cameo Corporate Services Limited, for the quarter ended March 31, 2026. The certificate confirms that securities received for dematerialization were processed and listed on the stock exchanges within the required 15-day timeframe.